StonvexLoading…
StonvexStonvexStonvexCore line items from TGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $27.07M | $22.62M | $25.14M | $25.00M |
Operating Income | $-8.24M | $-4.53M | $-4.41M | $-2.35M |
Net Income | $-8.25M | $-4.76M | $-4.60M | $-2.45M |
EPS (Diluted) | $-0.30 | $-0.19 | $-0.19 | $-0.10 |
Total Assets | $36.99M | $31.09M | $27.79M | $28.25M |
Total Liabilities | $15.52M | $20.97M | $13.14M | $9.27M |
Cash & Equivalents | $12.43M | $5.41M | $1.35M | $1.91M |
Free Cash Flow OCF − CapEx | $-10.31M | $3.09M | $-864.66K | $-1.67M |
Shares Outstanding | 29.85M | 24.95M | 24.85M | 24.85M |